Conversion of human umbilical cord mesenchymal stem cells in Wharton's Jelly to dopaminergic neurons in vitro: Potential therapeutic application for Parkinsonism

Stem Cells

Volumn 24, Issue 1, 2006, Pages 115-124

  Fu, Yu Show ^a   Cheng, Yun Chih ^a   Lin, Maan Yuh Anya ^a,b   Cheng, Henrich ^a,b   Chu, Pei Ming ^a   Chou, Shih Chich ^a   Shih, Yang Hsin ^b,c   Ko, Miau Hwa ^d   Sung, Min Shan ^d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Dopaminergic neuron; Human umbilical mesenchymal stem cells; Parkinson's disease; Transplantation; Tyrosine hydroxylase

Indexed keywords

AMPHETAMINE; CATECHOLAMINE; DOPAMINE; FIBROBLAST GROWTH FACTOR 8; OXIDOPAMINE; SONIC HEDGEHOG PROTEIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL MIGRATION; CELL TRANSFORMATION; CELL VIABILITY; CIRCLING BEHAVIOR; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE MODEL; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OUTCOME ASSESSMENT; PARKINSON DISEASE; PARKINSONISM; RAT; UMBILICAL CORD; WHARTON JELLY;

AMPHETAMINE; ANIMALS; BRAIN; CELL DIFFERENTIATION; CORD BLOOD STEM CELL TRANSPLANTATION; CULTURE MEDIA, CONDITIONED; DISEASE MODELS, ANIMAL; DOPAMINE; FETAL BLOOD; HUMANS; MESENCHYMAL STEM CELLS; NEURONS; PARKINSONIAN DISORDERS; PHENOTYPE; RATS; RATS, SPRAGUE-DAWLEY; ROTATION; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; ERINACEIDAE; PARKINSONIA;

EID: 33645532494     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2005-0053     Document Type: Article

References (54)

1. Hornykiewicz O. Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev 1996;18:925-964.
2. Bernheimer H, Birkmayer W, Hornykiewicz O et al. Brain dopamine and the syndromes of Parkinson and Huntington: clinical, morphological and neurochemical correlations. J Neurol Sci 1973;20:415-455.
3. Nagatsu T, Yamaguchi T, Rahman MK et al. Catecholamine-related enzymes and the biopterin cofactor in Parkinson's disease and related extrapyramidal diseases. Adv Neurol 1984;40:467-473.
4. Agid Y, Javoy-Agid F, Ruberg M. Biochemistry of neurotransmitter in Parkinson's disease. In: Marsden CD, Fahn S. eds. Movement Disorder. London: Butterworths. 1987:166-230.
5. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease: pathophysiologic and clinical implications. N Engl J Med 1988;318:876-880.
6. Damier P, Hirsch EC, Agid Y et al. The substantia nigra of the human brain. II: patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 1999;122:1437-1448.
7. Cotzias CG, Van Woert MH, Schiffer LM. Aromatic amino acids and modification of parkinsonism. N Engl J Med 1967;276:374-379.
8. Olanow CW, Tatton WG. Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 1999;22:123-144.
9. Backlund EO, Granberg PO, Hamberger B et al. Transplantation of adrenal medullary tissue to striatum in parkinsonism: first clinical trials. J Neurosurg 1985;62:169-173.
10. Madrazo I, León V, Torres C et al. Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson's disease. N Engl J Med 1988;318:51.
11. Lindvall O. Transplantation into the human brain: present status and future possibilities. J Neurol Neurosurg Psychiatry Jun(suppl) 1989:39-54.
12. Date I, Imaoka T, Miyoshi Y et al. Chromaffin cell survival and host dopaminergic fiber recovery in a patient with Parkinson's disease treated by cografts of adrenal medulla and pretrunsected peripheral nerve: case report. J Neurosurg 1996;84:685-689.
13. Deacon T, Schumacher J, Dinsmore J et al. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat Med 1997;3:350-353.
14. Mahowald MB, Areen J, Hoffer BJ et al. Transplantation of neural tissue from fetuses. Science 1987;235:1307-1308.
15. Spencer DD, Robbins RJ, Naftolin F et al. Unilateral transplantation of human letal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med 1992;327:1541-1548.
16. Freed CR, Breeze RE, Rosenberg NL et al. Survival of implanted letal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med 1992;327:1549-1555.
17. Kordower JH, Freeman TB, Snow BJ et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 1995;332:1118-1124.
18. Olanow CW, Kordower JH, Freeman TB. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci 1996;19:102-109.
19. Kordower JH, Freeman TB, Chen EY et al. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov Disord 1998;13:333-393.
20. Hauser RA, Freeman TB, Snow BJ et al. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch Neurol 1999;56:179-187.
21. Lindvall O. Cerebral implantation in movement disorders: state of the art. Mov Disord 1999;14:201-205.
22. Piccini P, Brooks DJ, Bjorklund A et al. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci 1999;2:1137-1140.
23. Freed CR, Greene PE, Breeze RE et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001;344:710-719.
24. Clarkson ED. Fetal tissue transplantation for patients with Parkinson's disease: a database of published clinical results. Drugs Aging 2001;18:773-785.
25. Mendez I, Dagher A, Hong M et al. Simultaneous intrastriatal and intramigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases. J Neurosurg 2002;96:589-596.
26. Ben-Hur T, Idelson M, Khaner H et al. Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in parkinsonian rats. STEM CELLS 2004;22:1246-1255.
27. Greely HT, Hamm T, Johnson R et al. The ethical use of human fetal tissue in medicine. N Engl J Med 1989;320:1093-1096.
28. Mitchell KE, Weiss ML, Mitchell BM. Matrix cells from Wharton's jelly form neurons and glia. STEM CELLS 2003;21:50-60.
29. Fu YS, Shin YT, Cheng YC et al. Transformation of human umbilical mesenchymal cells into neurons in vitro. J Biomed Sci 2004;11:652-660.
30. Wang HS, Hung SC, Pong ST et al. Mesenchymal stem cells in wharton jelly of the human umbilical cord. STEM CELLS 2004;22:1330-1337.
31. Lee SH, Lumelsky N, Studer L et al. Efficient generation of midbrain und hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 2000;218:675-679.
32. Zhang SC, Wernig M, Duncan ID et al. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 2001;19:1129-1133.
33. Nikkhah G, Duan WM, Knappe U et al. Restoration of complex sensorimotor behavior and skilled forelimb use by a modified nigral cell suspension transplantation approach in the rat Parkinson model. Neuroscience 1993;56:33-43.
34. Olsson M, Nikkhah G, Bentlage C et al. Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci 1995;15:3863-3875.
35. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates, ed 2. San Diego: Academic Press. 1986.
36. Arbuthnott G, Fuxe K, Ungerstedt U. Central catecholamine turnover and self-stimulation behaviour. Brain Res 1971;27:406-413.
37. Ungerstedt U, Arbuthnott GW. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 1970;24:485-493.
38. Ungerstedt U. Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiol Scand Suppl 1971;367:49-68.
39. Chinch CC, Zukowaka-Grojee Z, Kirk KL et al. 6-Fluoro-catecholamines as false adrenergic neurotransmitters. J Pharmacol Exp Ther 1983;225:529-533.
40. Kobayashi K, Kiuchi K, Ishii A et al. Expression of four types of human tyrosine hydroxylase in COS cells. FEBS Lett 1988;238:431-434.
41. Haycock JW. Multiple forms of tyrosine hydroxylase in human neuroblastoma cells: quantitation with isoform-specific antibodies. J Neurochem 1993;60:493-502.
42. Gahn LG, Roskoski R Jr. Tyrosine hydroxylase purification from rat PC 12 cells. Protein Expr Purif 1991;2:10-14.
43. Bjorklund A. Neurobiology: better cells for brain repair. Nature 1993;362:414-415.
44. Kim TE, Lee HS, Lee YB et al. Sonic hedgehog and FGF8 collaborate to induce dopaminergic phenotypes in the Nurr1-overexpressing neuronal stem cell. Biochem Biophys Res Commun 2003;305:1040-1048.
45. Perrier AL, Tahar V, Barberi T et al. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A 2004:101:12543-12548.
46. Buytaert-Hoefen KA, Alvarez E, Freed CR. Generation of tyrosine hydroxylase positive neurons from human embryonic stem cells after coculture with cellular substrates and exposure to GDNF. STEM CELLS 2004;22:669-674.
47. Rolletschek A, Chang H, Guan K et al. Differentiation of embryonic stem cell-derived dopaminergic neurons is enhanced by survival-promoting factors. Mech Dev 2001;105:93-104.
48. Stull ND, Jung JW, Iacovitti L. Induction of a dopaminergic phenotype in cultured striatal neurons by bone morphogenetic proteins. Brain Res Dev Brain Res 2001;130:91-98.
49. Okabe S, Forsberg-Nilsson K, Spiro AC et al. Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro. Mech Dev 1996;59:89-102.
50. Kim JY, Koh HC, Lee JY et al. Dopaminergic neuronal differentiation from rat embryonic neural precursors by Nurr1 overexpression. J Neurochem 2003;85:1443-1454.
51. Nishimura F, Yoshikawa M, Kanda S et al. Potential use of embryonic stem cells for the treatment of mouse parkinsonian models: improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells. STEM CELLS 2003;21:171-180.
52. Brundin P, Nilsson OG, Gage FH et al. Cyclosporin A increases survival of cross-species intrastriatal grafts of embryonic dopamine-containing neurons. Exp Brain Res 1985;60:204-208.
53. Galpern WR, Burns LH, Deacon TW et al. Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of Parkinson's disease: functional recovery and graft morphology. Exp Neurol 1996;140:1-13.
54. Clarke DJ, Brundin P, Strecker RE et al. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: ultrastructural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry. Exp Drain Res 1988;73:115-126.